Загрузка...
Oncologists’ Barriers and Facilitators for Oncotype DX Use: Qualitative Study
BACKGROUND: Oncotype DX (ODX), a tumor gene profiling test, has been incorporated into clinical guidelines to aid in adjuvant chemotherapy decision-making for early-stage, hormone receptor positive breast cancer patients. Despite US guidelines, less than half of eligible women receive testing. Reaso...
Сохранить в:
| Опубликовано в: : | Int J Technol Assess Health Care |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526532/ https://ncbi.nlm.nih.gov/pubmed/27958190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S026646231600060X |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|